Charlotte M Mckee, MD in Cambridge, MA - Internal Medicine

Charlotte M Mckee, MD is a Internal Medicine - Pulmonary Disease physician based in Cambridge, Massachusetts. Charlotte M Mckee is licensed to practice in Massachusetts (license number 153921) and her current practice location is 300 Technology Sq, 3rd Floor, Cambridge, Massachusetts. She can be reached at her office (for appointments etc.) via phone at (617) 452-1300.

NPI number for Charlotte M Mckee is 1174504070 and her current mailing address is 300 Technology Sq, 3rd Floor, Cambridge, Massachusetts. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1174504070.

Contact Information

	Charlotte M Mckee, MD
	300 Technology Sq, 3rd Floor, Cambridge, MA 02139-3515
	(617) 452-1300
	(617) 354-8300

Physician's Profile

Full Name	Charlotte M Mckee
Gender	Female
Speciality	Internal Medicine - Pulmonary Disease
Location	300 Technology Sq, Cambridge, Massachusetts
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1174504070
Provider Enumeration Date: 11/08/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Charlotte M Mckee such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1174504070	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RP1001X	Internal Medicine - Pulmonary Disease	153921 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Charlotte M Mckee is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Charlotte M Mckee, MD 300 Technology Sq, 3rd Floor, Cambridge, MA 02139-3515 Ph: (617) 452-1300	Charlotte M Mckee, MD 300 Technology Sq, 3rd Floor, Cambridge, MA 02139-3515 Ph: (617) 452-1300

News Archive

Tzamal Medical, Duchesnay partner to distribute and sell Diclectin for management of NVP

Duchesnay Inc. and Tzamal Medical Group Ltd today announced that they have signed an agreement whereby Tzamal Medical Group has been granted exclusive rights to distribute and sell throughout the Israeli market the prescription medicine Diclectin (doxylamine 10 mg/pyridoxine 10 mg delayed-release tablet) indicated for the management of nausea and vomiting of pregnancy (NVP).

Novartis NVA23 Phase III trial in COPD achieves primary end point

Sosei Group Corporation announces that NVA237, a long-acting muscarinic antagonist being investigated as a once daily treatment for chronic obstructive pulmonary disease, achieved its primary end point in a Phase III study.

Infectious diseases from animals likely to cause further pandemics

As humans move to cities to settle, there is a sharp decline in biodiversity leading to several disturbances in the balance and relationship between humans and wild animals. A new study from researchers at the University of California, Davis' One Health Institute, shows that this has led to the spread of zoonotic viruses from animals to humans, such as COVID-19, which has caused a global pandemic involving over 184 countries and territories. The study was published in the latest issue of Proceedings of the Royal Society B.

QF-CMV test helps predict transplant recipients at increased risk of CMV disease after surgery

New international guidelines published in the journal Transplantation reinforce the use of a new type of blood test to assess cytomegalovirus (CMV) risk in solid organ transplant recipients (i.e. transplant recipients). This blood test, QuantiFERON®-CMV (QF-CMV), is the first commercially-available blood test to allow physicians to monitor a person's risk of CMV disease. Most commonly used in the transplant setting, QF-CMV may predict which transplant recipients are at increased risk of CMV disease after transplant surgery.

Scientific evidence: REHIT session on a CAROL bike contributes to greater post-exercise metabolism

The results recently published by the American Council on Exercise are significant because a meaningful increase in EPOC over the long term can have an important impact on calorie expenditure and help people achieve weight loss and weight maintenance and improve their fitness.

Internal Medicine Doctors in Cambridge, MA

Yun- Ting Eric Yeh, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 300 Mount Auburn St Ste 310, Cambridge, MA 02138 Phone: 617-497-1560 Fax: 617-497-1190
Dr. Catharine M. Mintzer, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 725 Concord Ave, Suite 4100, Cambridge, MA 02138 Phone: 617-864-8822 Fax: 617-547-5367
Kenneth J. Gold, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 75 Mount Auburn St, Huhs, Cambridge, MA 02138 Phone: 617-495-8414 Fax: 617-496-0560
Dr. Margaret Love Mclaughlin, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 300 Mount Auburn St, Suite 515, Cambridge, MA 02138 Phone: 617-864-1571 Fax: 617-864-1507
Dr. Valerie Pronio-stelluto, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-499-5140 Fax: 617-499-5593
Dr. Ayse A. Atasoylu, M.D., M.P.H. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 29 Everett St, Cambridge, MA 02138 Phone: 617-349-8222
Dr. Alexandra Vania Chabrerie, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn Street, Department Of Medicine, Cambridge, MA 02138 Phone: 617-492-3500

Charlotte M Mckee, MD - Internal Medicine in Cambridge, MA